Biogen signs $1.5bn depression drug deal with Sage Therapeutics - Pharmaceutical Business Review

Submitted by Anonymous (not verified) on Mon, 11/30/2020 - 12:42

Biogen signs $1.5bn depression drug deal with Sage Therapeutics  Pharmaceutical Business Review